Stoke Therapeutics, Inc. (STOK) Covered Calls

You can sell covered calls on Stoke Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for STOK (prices last updated Fri 4:16 PM ET):

Stoke Therapeutics, Inc. (STOK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.41 +0.72 11.28 12.38 892K - 0.5
Covered Calls For Stoke Therapeutics, Inc. (STOK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 12.5 1.05 11.33 9.3% 154%
Jun 21 12.5 1.45 10.93 13.3% 85.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide medicines to treat the underlying causes of severe genetic diseases. Its lead product candidate, STK-001 used to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics, Inc. has a partnership with Invitae Corporation to offer genetic testing. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was founded in 2014 and is headquartered in Bedford, Massachusetts.